Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - December 2012

Tablet Process Development and Validation and the application of QbD (3 day)

11 Dec 2012 - 13 Dec 2012 - County House, 221-241 Beckenham Road, Beckenham, BR3 4UF, Nr London

Bookmark and Share

This interactive workshop provides up-to-date, relevant and detailed information on the impact of Quality by Design (QbD) on the Development and Validation of tablet manufacturing processes. It will also study the identification and evaluation of Critical Product Attributes and Critical Process Parameters for tablets, and their implications for process control. We develop new concepts including the use of risk and process matrices for risk management. The latest ICH and FDA guidance on Quality by Design and Process Development, published in 2009, will be comprehensively reviewed. The hands-on workshop day will enable you to experience at first hand the impact of processing parameters on product quality.

By the end of the course, you will

·         Understand the relationship between the principles of QbD and tablet development and process validation in generic and new product development

·         Understand the relationship between material properties, formulation development and process development

·         Understand the processes commonly used to manufacture tablets and the factors which affect them. Recognise how to identify critical processing parameters, and how to incorporate into a process validation program

·         Understand the principles of PAT, how and where it can be most effectively deployed

·         Know the latest FDA thinking on Process Development including the three key steps of validation

·         Gain practical hands on experience of the impact of processing parameters on product quality on the small scale.

       Who should attend?
The  course  is designed  for people new  to Process Development,  and  those  requiring  a
refresher in the area.  It will also benefit Process Development experts wishing to extend
their understanding of why products processes can go wrong, and regulatory and quality
personnel who need to understand the development process better.  The course will include the latest FDA guidance on the development of generic products under QbD.

       Course outline:
Day 1: 
Morning - Product development 
• Principles of Quality by Design and the product development process 
• Linking material properties to formulation and processing behaviour 
• FDA Guidance on Process Validation 
Workshop session - Understanding Quality by Design 
  Afternoon -
Mixing, and dry granulation 
• Identifying potential Critical Process Parameters. 
• Unit processes 1 - Mixing and blending 
• Assessing blend uniformity. Sampling problems and practice 
Workshop session - blend assessment practical. Effect of material properties on    powder
 mixing behaviour 
Day 2: 
Morning - EFPIA Case study. Wet granulation 
• The new regulatory landscape. Q8, Q9 and Q10 and their impact on product and
process development. 
• EFPIA case study  -  what would a QbD regulatory submission look like? 
• Use of Process Matrices in process development 
• Developing wet granulation processes 
• Granulation endpoint control 
  Afternoon -
Drying, compression and film coating 
• Drying  -  techniques and process control 
• Compression  -  opportunities and threats! 
• Developing film coating processes 
• Round-up session 
Day 3: Practical 
• Blending 
• Granulation 
• Drying 
• Milling 
• Sieving 
• Compression 
• Granule and product characterisation 
Wherever possible participants should bring practical problems and examples which can
be reviewed on the course. The course will be highly participative and useful for people
with or without experience. Numbers are restricted to guarantee personal involvement.    

Ful  Course Speakers
Dr Michael Gamlen is Managing Director of Pharmaceutical Development Services Ltd, 
a pharmaceutical consultancy based in Nottingham (UK).

       Dr Dipankar Dey, PharmaTraining Ltd - Dipankar Dey recently joined PharmaTraining Ltd as Training Manager.

        Full Fee: 3 day course £1770.00 (+ VAT £354.00 if applicable, see notes on VAT)  

Discount of 10% applies for booking 8 weeks in advance. Discount of 10% applies for booking more than 1 delegate. Discount of 10% applies for booking more than 1 course.

Maximum discount received is 15%


Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos